-
Forward Look
The Vitamin HypeResearchers find no evidence that supplements reduce cancer risk.
by Stephen Ornes
-
A Balancing Act
Diabetes increases cancer risk, and a dual diagnosis of cancer and diabetes complicates treatment and prognosis.
by Stephen Ornes
-
Healthy Habits
A Protein PuzzleStudy links higher protein consumption to a greater chance of cancer death, but risk may depend on age.
by Alanna Kennedy-Gorman
-
Unleashing the Immune System
New treatments that harness the power of the immune system are taking aim at many common cancers.
by Alexandra Goho
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
Unraveling the Genetics of CancerQ&A with Li Ding on The Cancer Genome Atlas
by Yasmine Iqbal
-
Forward Look
An Herbal SurpriseWhat's inside the herbal supplement may not match what's on the label.
by Stephen Ornes
-
Forward Look
Gut ReactionNew research suggests a link between gut bacteria and colorectal cancer.
by Melissa Weber
-
Forward Look
Affordable Care Act to Cover Breast Cancer Risk Reduction DrugsMedications are an option for high-risk women, but few use them.
by Sue Rochman
-
Forward Look
Push Needed to Increase HPV Vaccination RatesPresident's Cancer Panel stresses reducing 'missed opportunities.'
by Sue Rochman
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles